Title : PARP inhibitors and immunotherapy in ovarian and endometrial cancers.

Pub. Date : 2021 Dec

PMID : 33882241






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Several PARP inhibitors, which target defective DNA repair have been approved as maintenance therapy for advanced ovarian cancer in both the first line and platinum sensitive relapsed settings. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens